Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Botswana-University of Pennsylvania Partnership, Gaborone, Botswana.
BMC Womens Health. 2021 Jul 6;21(1):267. doi: 10.1186/s12905-021-01402-5.
Cervical cancer is the leading cause of female cancer mortality in Botswana with the majority of cervical cancer patients presenting with late-stage disease. The identification of factors associated with late-stage disease could reduce the cervical cancer burden. This study aims to identify potential patient level clinical and sociodemographic factors associated with a late-stage diagnosis of cervical cancer in Botswana in order to help inform future interventions at the community and individual levels to decrease cervical cancer morbidity and mortality.
There were 984 women diagnosed with cervical cancer from January 2015 to March 2020 at two tertiary hospitals in Gaborone, Botswana. Four hundred forty women (44.7%) presented with late-stage cervical cancer, and 674 women (69.7%) were living with HIV. The mean age at diagnosis was 50.5 years. The association between late-stage (III/IV) cervical cancer at diagnosis and patient clinical and sociodemographic factors was evaluated using multivariable logistic regression with multiple imputation. Women who reported undergoing cervical cancer screening had lower odds of late-stage disease at diagnosis (OR: 0.63, 95% CI 0.47-0.84) compared to those who did not report screening. Women who had never been married had increased odds of late-stage disease at diagnosis (OR: 1.35, 95% CI 1.02-1.86) compared to women who had been married. Women with abnormal vaginal bleeding had higher odds of late-stage disease at diagnosis (OR: 2.32, 95% CI 1.70-3.16) compared to those without abnormal vaginal bleeding. HIV was not associated with a diagnosis of late-stage cervical cancer. Rural women who consulted a traditional healer had increased odds of late-stage disease at diagnosis compared to rural women who had never consulted a traditional healer (OR: 1.61, 95% CI 1.02-2.55).
Increasing education and awareness among women, regardless of their HIV status, and among providers, including traditional healers, about the benefits of cervical cancer screening and about the importance of seeking prompt medical care for abnormal vaginal bleeding, while also developing support systems for unmarried women, may help reduce cervical cancer morbidity and mortality in Botswana.
宫颈癌是博茨瓦纳女性癌症死亡的主要原因,大多数宫颈癌患者就诊时已处于晚期。识别与晚期疾病相关的因素可以降低宫颈癌负担。本研究旨在确定博茨瓦纳与宫颈癌晚期诊断相关的潜在患者水平临床和社会人口统计学因素,以便为未来在社区和个人层面开展干预提供信息,以降低宫颈癌发病率和死亡率。
在博茨瓦纳哈博罗内的两家三级医院,从 2015 年 1 月至 2020 年 3 月期间共诊断出 984 名宫颈癌女性患者。444 名女性(44.7%)就诊时为宫颈癌晚期,674 名女性(69.7%)携带艾滋病毒。诊断时的平均年龄为 50.5 岁。使用多变量逻辑回归和多重插补评估了诊断时晚期(III/IV 期)宫颈癌与患者临床和社会人口统计学因素之间的关联。与未报告筛查的女性相比,报告接受宫颈癌筛查的女性诊断为晚期疾病的可能性较低(OR:0.63,95%CI 0.47-0.84)。从未结婚的女性与诊断为晚期疾病的几率增加相关(OR:1.35,95%CI 1.02-1.86)相比,已婚女性。与无异常阴道出血的女性相比,有异常阴道出血的女性诊断为晚期疾病的几率更高(OR:2.32,95%CI 1.70-3.16)。艾滋病毒与晚期宫颈癌诊断无关。与从未咨询过传统治疗师的农村女性相比,咨询过传统治疗师的农村女性诊断为晚期疾病的几率增加(OR:1.61,95%CI 1.02-2.55)。
无论艾滋病毒状况如何,提高妇女和卫生保健提供者(包括传统治疗师)对宫颈癌筛查益处以及对异常阴道出血及时就医重要性的认识,同时为未婚妇女建立支持系统,可能有助于降低博茨瓦纳的宫颈癌发病率和死亡率。